Home Podcasts M&A Science
M&A Science

M&A Science

Kison Patel 417 Episodes Jul 23, 2026

M&A Science, hosted by Kison Patel (Founder & CEO of DealRoom), is a podcast dedicated to mastering mergers and acquisitions. Each week, Kison and expert guests from leading brands like Xerox, FastLap, and Cisco discuss real-world M&A strategies, offering actionable insights on sourcing, due diligence, integration, and divestitures. With over 300 episodes, it serves as a premier thought leadership resource for both experienced practitioners and newcomers. The podcast is brought to you by DealRoom, an M&A optimization platform.

Episodes

What Buyers Want from Bankers and Founders
What Buyers Want from Bankers and Founders Jul 23, 2026 50:41 Andrew Morbitzer, VP of Corporate Development, Life360 (ASX: 360) Your standard teaser tells a buyer everything about your company and nothing about why you fit their strategy right now. When sellers expect the buyer to figure out that alignment, the deal dies on the desk. Andrew Morbitzer has led more than $2 billion in acquisitions at Intuit and GoDaddy, worked on the sell-side as an M&A advisor
220 Deals. One Playbook. How to Scale M&A Without Losing Control
220 Deals. One Playbook. How to Scale M&A Without Losing Control Jul 16, 2026 48:21 Shawn Rodricks, Head of M&A - Independent Consultant If you scale the deal flow without the operating infrastructure to match it, things break fast. The playbook is a document nobody opens, closing weeks turn into fire drills, and the returns you modeled start to slip. Shawn Rodricks, Head of M&A - Independent Consultant, built the infrastructure before the volume hit. He closed 220 acquisitions
How to Build a Deal Model That Beats PE on Price
How to Build a Deal Model That Beats PE on Price Jul 9, 2026 53:08 Jeremy Segal, Executive Vice President of Corporate Development, Progress (NASDAQ: PRGS) Buyers who mistake a high LOI bid for a winning strategy are easy prey for sellers who know the growth equity playbook. Jeremy Segal's position: precision at the LOI stage is a stronger differentiator than price. Jeremy Segal is EVP of Corporate Development at Progress (NASDAQ: PRGS), a publicly traded softwa
The People You Lose in M&A: Key Talent Retention Before Close
The People You Lose in M&A: Key Talent Retention Before Close Jul 2, 2026 58:41 Haseeb Jawad, VP and Head of Corporate Development, Commvault (NASDAQ: CVLT) The people who leave post-close are usually the ones the deal depended on. Which means the problem starts with how you read culture before LOI and whether financial incentives are the only retention tool you are building with. Haseeb Jawad heads corporate development at Commvault, running a lean team with full accountabi
How to Buy Companies That Aren't Profitable Yet
How to Buy Companies That Aren't Profitable Yet Jun 25, 2026 54:53 Matt Arsenault, VP of Corporate Development & Strategic Alliances at Jamf Venture-backed companies are priced at their future state, not their current revenue. When growth stalls and another fundraising round stops making sense, the gap between VC valuation and what a strategic buyer will pay becomes the hardest conversation in any deal process. Matt Arsenault, VP of Corporate Development & Str
When Deals Get Weird: Stories You Don't See in the CIM
When Deals Get Weird: Stories You Don't See in the CIM Jun 18, 2026 01:00:38 Nathan Rust, Lutz Lehmann, Troy Pospisil, Jeremy Segal, Patrick Mumman, Tej Brahmbhatt, George Helock, and Angie Astle Eight deal professionals share the M&A moments that never make the CIM. A birthday cake in a management presentation that confirmed a culture fit and influenced a bid. A buyer who died before close, forcing a nine-month restart from scratch. Eight years of customer revenue data on
The Real Work Behind the Close: When Judgment Beats the Checklist
The Real Work Behind the Close: When Judgment Beats the Checklist Jun 11, 2026 57:10 Brent Baxter, Sam Delestienne, Steve Hoffman, John Strenger, and Matt Melsen Winning a banker-run auction at 5% under the highest bid. Closing a deal when co-sellers have not spoken in months. Getting through 22 countries of employment complexity with a client who refused to work with EOR providers. Acquiring a Netherlands-based public company and discovering the due diligence documents were in Du
The Nordic Compounder Playbook: How Jörgen Wigh Runs 85 Companies With 22 HQ Staff and No Integration
The Nordic Compounder Playbook: How Jörgen Wigh Runs 85 Companies With 22 HQ Staff and No Integration Jun 4, 2026 40:10 Jörgen Wigh, CEO of Lagercrantz Group Lagercrantz Group has completed 90+ acquisitions over 20 years and never sold one. CEO Jörgen Wigh runs 85 niche B2B companies under a 22-person headquarters with no integration, no exits, and no value realization targets. This is Part 2 of 2. Part 1 covers the deal model, while Part 2 is the operating culture. Jörgen gets into how 85 autonomous companies are
The Nordic Compounder Playbook: How Lagercrantz Bought 90 Companies and Never Sold One
The Nordic Compounder Playbook: How Lagercrantz Bought 90 Companies and Never Sold One May 28, 2026 42:52 Jörgen Wigh, CEO of Lagercrantz Group Jörgen Wigh has been CEO of Lagercrantz Group (STO: LAGR-B) for over 20 years. In that time he completed 90+ acquisitions, built a portfolio of 85 niche B2B companies, and delivered 15 consecutive years of record earnings per share. No capital raises. No forced integration. No exits. The Nordic compounder model has quietly outperformed global markets for decad
M&A Integration Technology: What Actually Works
M&A Integration Technology: What Actually Works May 21, 2026 50:55 Jim Buckley, VP M&A Integration at Coursera | Todd Manley, VP of Corp Dev Integration at Intel | Carey Pugh is Sr. Director, M&A Corporate Integration at Ansys | Mahesh Ganesan, Sr. Director, M&A Integration at UKG Four integration leaders from Intel, Coursera, Ansys, and UKG debate what integration technology actually delivers versus what creates expensive overhead and where the real value leaks
Partner Before You Buy: The Pre-Acquisition Strategy Corp Dev Teams Skip
Partner Before You Buy: The Pre-Acquisition Strategy Corp Dev Teams Skip May 14, 2026 52:57 Tomer Stavitsky is SVP and Chief Corporate Development Officer at Omnicell (NASDAQ: OMCL) Corp dev teams treat M&A and partnerships as separate tracks, but Tomer Stavitsky looks at them holistically. In this episode, he breaks down the partner-first approach: an acquisition framework for situations where the target isn't ready, the PE owner isn't selling, or your integration capacity isn't there.
How M&A Turns a Chemical Company Into a Tech Business
How M&A Turns a Chemical Company Into a Tech Business May 7, 2026 53:55 Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc. Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc., breaks down how a commodity chemical company uses M&A to transform into a technology-enabled, chemistry-as-a-service business. He covers the acquisition of an AI and MarTech company, the build vs. buy vs. partner decision framework, integration planning dis

Recommended